Erika Hamilton, Breast Executive Committee Director at Sarah Cannon Research Institute, shared a post on LinkedIn:
“FDA-ASCO joint workshop on reproductive toxicity and how we should be better monitoring/measuring this in clinical trials.
Happy to join this panel. Open to the public.
Agenda and registration here.”
Source: Erika Hamilton/LinkedIn